Profen and Eucalyptus globulus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Profen (ibuprofen) and Eucalyptus globulus (eucalyptus). Common drug interactions include arthralgia among females and ankylosing spondylitis among males.

The phase IV clinical study analyzes what interactions people have when they take Profen and Eucalyptus globulus. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.

What is Eucalyptus globulus?

Eucalyptus globulus has active ingredients of eucalyptus. eHealthMe is studying from 66 Eucalyptus globulus users. Check the latest studies of Eucalyptus globulus.

On Jul, 10, 2026

11 people who take Profen and Eucalyptus globulus together, and have interactions are studied.

Profen and Eucalyptus globulus drug interactions.

What are the common drug interactions of Profen and Eucalyptus Globulus, by gender? *:

female:

Arthralgia (joint pain)
Arthropathy
Bacterial infection
Contusion (a type of hematoma of tissue in which capillaries)
Diarrhoea
Drug hypersensitivity
Drug ineffective
Drug intolerance (drug sensitivity)
Eating disorder
Fall

male:

Ankylosing spondylitis (type of arthritis affecting the spine)
Blood lactic acid increased
Grip strength decreased
Injection site pain
Insomnia (sleeplessness)
Myalgia (muscle pain)
Nasopharyngitis (inflammation of the nasopharynx)
Pyrexia (fever)
Sacroiliitis (an inflammation of the sacroiliac joint)
Sinus disorder (disease of sinus)

What are the common drug interactions of Profen and Eucalyptus Globulus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Weight increased

20-29:

n/a

30-39:

n/a

40-49:

Arthralgia (joint pain)
Arthropathy
Drug hypersensitivity
Drug ineffective
Drug intolerance (drug sensitivity)
Gastrointestinal toxicity (damage to digestive tract by any substance)
Hepatotoxicity (chemical-driven liver damage)
Infection
Joint injury
Joint stiffness

50-59:

Ankylosing spondylitis (type of arthritis affecting the spine)
General physical health deterioration (weak health status)
Grip strength decreased
Injection site pain
Insomnia (sleeplessness)
Myalgia (muscle pain)
Nasopharyngitis (inflammation of the nasopharynx)
Pyrexia (fever)
Sacroiliitis (an inflammation of the sacroiliac joint)
Sinus disorder (disease of sinus)

60+:

Influenza

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 27.27%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 27.27%
Immunodeficiency Common Variable: 2 people, 18.18%
Partial Seizures (seizures which affect only a part of the brain at onset): 1 person, 9.09%
Joint Pain: 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Cough: 1 person, 9.09%
Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 1 person, 9.09%
Cardiac Failure: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Profen and Eucalyptus globulus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously